Brief: Ryvu Therapeutics Q1 Net Loss At 25.3 Mln Zlotys
22/05/2025 16:06
May 22 (Reuters) - Ryvu Therapeutics SA RVU.WA: Q1 NET LOSS AT 25.3 MILLION ZLOTYS Q1 SALES REVENUE AT 16.9 MILLION ZLOTYS Q1 OPERATING LOSS AT 37.7 MILLION ZLOTYS Source text: nEM1Kh3Mva Further company coverage: RVU.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project